Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06954402 · ClinicalTrials.gov registry record · NA
Resilience Among Individuals With Opioid Use Disorder
A NA study, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT06954402: Recruiting NA study, sponsored by Johns Hopkins University.
NCT06954402 is a NA study that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 125 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06954402, a NA study, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to develop a human laboratory model of resilience in people with opioid use disorder (OUD). The investigators aim to learn if objective tasks that measure cognitive, emotional, and control aspects of resilience match up with self-reported resilience during stress and non-stress situations.
Primary Outcome
Instrument: Connor-Davidson Resilience Scale 25 Score Range: 0-100 Interpretation: Higher scores indicate greater resilience.
Interventions
- BEHAVIORAL Acute Stress Intervention (MAST-based)
- BEHAVIORAL Non-Stress Intervention (NST-based)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2026-05-29 |
| Est. Completion | 2029-04-30 |
| Phase | NA |
What NCT06954402 shows while recruiting
NCT06954402 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Acute Stress Intervention (MAST-based) is the first listed.
NCT06954402 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06954402 about?
NCT06954402 is a clinical study titled "Resilience Among Individuals With Opioid Use Disorder". The goal of this clinical trial is to develop a human laboratory model of resilience in people with opioid use disorder (OUD). The investigators aim to learn if objective tasks that measure cognitive, emotional, and control aspects of resilience match up with self-reported resilience during stress a...
What is the current status of trial NCT06954402?
This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2026-05-29. Estimated completion is 2029-04-30.
What interventions are being tested in trial NCT06954402?
The interventions under investigation include: Acute Stress Intervention (MAST-based) (BEHAVIORAL), Non-Stress Intervention (NST-based) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06954402?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06954402's enrollment target sits among peer trials
125 753rd of 2000 higher than 1,243 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI